Skip to main content

Table 4 Quality of life in breast cancer patients before and after intervention in KD group and control group as measured by the EORTC QLQBR23a

From: Does a ketogenic diet have beneficial effects on quality of life, physical activity or biomarkers in patients with breast cancer: a randomized controlled clinical trial

  KD Control p-value
aFunctioning
 Future perspective
  Week 0 66 (33–100) 66 (33–66) 0/60
  Week 12 66 (33–66) 33 (33–100) 0/85
  p-value 0/45 0/76  
bSymptoms+
 Arm
  Week 0 11 (0–36) 11 (0–22) 0/36
  Week 12 11 (0–36) 22 (0–33) 88
  p-value 0/70 0/59  
 Breast
  Week 0 8 (0–33) 8 (0–25) 0/34
  Week 12 8 (0–10) 8 (0–16) 0/55
  p-value 0/01 0/34  
 Systemic therapy side effects
  Week 0 9 (4–17) 14 (4–23) 0/54
  Week 12 42 (20–52) 42 (33–52) 0/33
  p-value 0</001 0</001  
 Concerns over hair loss
  Week 0 0 0 0/20
  Week 12 66 (33–100) 33 (33–100) 0/50
  p-value 0</001 0</001  
  1. Mann–Whitney U test was used to compare the continuous variables between the two groups. Wilcoxon was used to compare the continuous variables within the two groups
  2. aThe higher values indicate higher level of functioning and quality of life
  3. bThe higher values indicate a higher grade of symptoms
  4. Data shown as median and quartile (25, 75)